Ronald M. Kurtz M.D., President & CEO at RxSight, Inc. (RXST), sold 62,500 shares at $43.50 ($2.8M) on 2024-01-08, disclosed to the SEC on 2024-01-09.
Scheduled sale ($2.8M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.50 | 31,250 | $1.4M | 49.2% |
| 2 | $45.00 | 31,250 | $1.4M | 50.8% |
| Total | $44.25 avg | 62,500 | $2.8M | 100% |
| Filing → |
| RXST | SELL | 2023-12-29 | $1.8M | — | Filing → |
| RXST | SELL | 2023-12-18 | $1.6M | — | Filing → |
| RXST | BUY | 2021-08-05 | $2.1M | — | Filing → |